Skip to main navigation
Skip to search
Skip to main content
Macquarie University Home
Help & FAQ
Home
Profiles
Research units
Projects
Research Outputs
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
MK3475-B61 - A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants with First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61)
Gurney, Howard
(Primary Chief Investigator)
Chapman, Nicola
(Clinical Trial Unit Staff)
Tan, Pearlyn
(Clinical Trial Unit Staff)
Faculty of Medicine, Health and Human Sciences
Project
:
Research
Overview
Project Details
Acronym
Keynote B61
Status
Active
Effective start/end date
1/02/21
→
10/12/25
View all
View less